Literature DB >> 18191791

Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin.

Xaver Sewald1, Bettina Gebert-Vogl, Sandra Prassl, Iris Barwig, Evelyn Weiss, Monica Fabbri, Radim Osicka, Matthias Schiemann, Dirk H Busch, Monika Semmrich, Bernhard Holzmann, Peter Sebo, Rainer Haas.   

Abstract

Helicobacter pylori infection is associated with gastritis, ulcerations, and gastric adenocarcinoma. H. pylori secretes the vacuolating cytotoxin (VacA), a major pathogenicity factor. VacA has immunosuppressive effects, inhibiting interleukin-2 (IL-2) secretion by interference with the T cell receptor/IL-2 signaling pathway at the level of calcineurin, the Ca2+-calmodulin-dependent phosphatase. Here, we show that VacA efficiently enters activated, migrating primary human T lymphocytes by binding to the beta2 (CD18) integrin receptor subunit and exploiting the recycling of lymphocyte function-associated antigen (LFA)-1. LFA-1-deficient Jurkat T cells were resistant to vacuolation and IL-2 modulation, and genetic complementation restored sensitivity to VacA. VacA targeted human, but not murine, CD18 for cell entry, consistent with the species-specific adaptation of H. pylori. Furthermore, expression of human integrin receptors (LFA-1 or Mac-1) in murine T cells resulted in VacA-mediated cellular vacuolation. Thus, H. pylori co-opts CD18 as a VacA receptor on human T lymphocytes to subvert the host immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191791     DOI: 10.1016/j.chom.2007.11.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  49 in total

1.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

Review 2.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

3.  Helicobacter pylori-induced interleukin-12 p40 expression.

Authors:  Eriko Takeshima; Koh Tomimori; Hiromitsu Teruya; Chie Ishikawa; Masachika Senba; Daniele D'Ambrosio; Fukunori Kinjo; Hitomi Mimuro; Chihiro Sasakawa; Toshiya Hirayama; Jiro Fujita; Naoki Mori
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

4.  Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance.

Authors:  Mathias Oertli; Manuel Noben; Daniela B Engler; Raphaela P Semper; Sebastian Reuter; Joachim Maxeiner; Markus Gerhard; Christian Taube; Anne Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 5.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 6.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

7.  Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner.

Authors:  Luisa F Jiménez-Soto; Stefan Kutter; Xaver Sewald; Claudia Ertl; Evelyn Weiss; Ulrike Kapp; Manfred Rohde; Torsten Pirch; Kirsten Jung; S Francesco Retta; Laurent Terradot; Wolfgang Fischer; Rainer Haas
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

Review 8.  Helicobacter pylori gamma-glutamyl transpeptidase and its pathogenic role.

Authors:  Vittorio Ricci; Maria Giannouli; Marco Romano; Raffaele Zarrilli
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

9.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

10.  Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells.

Authors:  Amanda Oldani; Mireille Cormont; Veronique Hofman; Valentina Chiozzi; Olivier Oregioni; Alexandra Canonici; Anna Sciullo; Patrizia Sommi; Alessia Fabbri; Vittorio Ricci; Patrice Boquet
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.